Treatment Guided by Comprehensive Genomic Profiling and Expert MTB Decision-Making Improves Outcomes in Pretreated Patients with Metastatic Cancer By Ogkologos - October 14, 2025 266 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ROME study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Lurbinectedin Zongertinib Shows Durable Antitumour Activity in First-Line Treatment for Patients with Previously Untreated HER2-mutated Advanced NSCLC Patient Guide on Immunotherapy Side Effects and Their Management Now Available Also in the Ukrainian MOST POPULAR Men’s skin cancer rates increase by 50% over decade June 24, 2021 Smoking among young adults increased by 25% during first lockdown August 25, 2021 Programme Highlights of the ESMO Virtual Congress 2020 [ESMO Media Alert] August 28, 2020 COVID-19: “The really hard part is we know what needs to... July 7, 2020 Load more HOT NEWS Should Surgery And Radiation Be The Standard Treatment For DCIS? The... Study Tests Immunotherapy in People with Cancer and Autoimmune Diseases ESMO Calls for Cancer Care Safeguards in the EU’s Health Crisis... Two-Time Breast Cancer Warrior Left Devastated After Package Full of Meds...
